Latest Episodes
The HER2 Diagnostic and Treatment Landscape in NSCLC
Episode 1: Identifying HER2-directed NSCLC: The Medical Oncologist and Pathologist perspectives This is the first episode of a two-part series on the HER2 diagnostic...
ER+ metastatic breast cancer: Key insights on elacestrant from the latest EMERALD subgroup analyses
In this podcast, Dr Aditya Bardia and Dr Virginia Kaklamani share their insights on the recent publication of the subgroup analyses from the phase...
Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer
This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer. Dr Rena Callahan and Dr Roberto Salgado...
Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions
Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions Key clinical takeaways: MMR status should be tested in all patients at diagnosis and...
Intermediate HCC – The evolving role of IO
Intermediate HCC – The evolving role of IO In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology...
Intermediate HCC – treatment options and strategies
In the third of this 4-part podcast series on HCC, the Oncology Brothers Dr Rahul and Dr Rohit Gosain are joined by Hepatologist Dr...